Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Dydrogesterone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR known ✓ | P06401 | 4/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | AR | P10275 | 2/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 2/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 2/20 | 1.00 |
| ▸ | TBXA2R | P21731 | 1/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.63 |
| ▸ | SERPINA6 | P08185 | 4/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | NR3C1 | P04150 | 3/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dydrogesterone SCHEMBL29335245 | 1.00 | CYP3A4 (1.00) | CYP3A4PGRALDH1A1CYP2C19AR | |
| Dydrogesterone SCHEMBL13907084 | 1.00 | CYP3A4 (1.00) | CYP3A4PGRALDH1A1CYP2C19AR | |
| Dydrogesterone SCHEMBL37703 | 1.00 | CYP3A4 (1.00) | CYP3A4PGRALDH1A1CYP2C19AR | |
| Dydrogesterone SCHEMBL23383832 | 1.00 | CYP3A4 (1.00) | CYP3A4PGRALDH1A1CYP2C19AR | |
| Dydrogesterone SCHEMBL18814051 | 1.00 | CYP3A4 (1.00) | CYP3A4PGRALDH1A1CYP2C19AR | |
| Dydrogesterone SCHEMBL23360787 | 1.00 | CYP3A4 (1.00) | CYP3A4PGRALDH1A1CYP2C19AR | |
| Dydrogesterone SCHEMBL20281282 | 1.00 | CYP3A4 (1.00) | CYP3A4PGRALDH1A1CYP2C19AR | |
| Dydrogesterone SCHEMBL606817 | 1.00 | CYP3A4 (1.00) | CYP3A4PGRALDH1A1CYP2C19AR | |
| Dydrogesterone SCHEMBL11512798 | 1.00 | CYP3A4 (1.00) | CYP3A4PGRALDH1A1CYP2C19AR | |
| Dydrogesterone SCHEMBL23360802 | 0.98 | CYP3A4 (0.96) | CYP3A4PGRALDH1A1CYP2C19AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11992431-B2 | Inserter | BAYER OY (FI) | 2024-05-28 | — | — | US | claimed |
| US-20210298942-A1 | INSERTER | BAYER OY (FI) | 2021-09-30 | — | — | US | claimed |
| US-10561524-B2 | Inserter | BAYER OY (FI) | 2020-02-18 | — | — | US | claimed |
| US-20170196728-A1 | INSERTER | BAYER OY (FI) | 2017-07-13 | — | — | US | claimed |
| EP-2305195-A1 | Drug delivery compositions for improved stability of steroids | Theratech, Inc. (US) | 2011-04-06 | — | — | EP | claimed |
| EP-1976997-B1 | PROCESS FOR THE PREPARATION OF 11BETA-HYDR0XY-9BETA,10ALPHA-STEROIDS EMPLOYING AMYCOLATOPSIS MEDITERRANEI CELLS | SOLVAY PHARM GMBH (DE) | 2009-04-08 | — | — | EP | claimed |
| EP-1976997-A1 | PROCESS FOR THE PREPARATION OF 11BETA-HYDR0XY-9BETA, 10ALPHA -STEROIDS EMPLOYING AMYCOLATOPSIS MEDITERRANEI CELLS | Solvay Pharmaceuticals GmbH (DE) | 2008-10-08 | — | — | EP | claimed |
| WO-2007082891-A1 | PROCESS FOR THE PREPARATION OF 11BETA-HYDR0XY-9BETA, 10ALPHA -STEROIDS EMPLOYING AMYCOLATOPSIS MEDITERRANEI CELLS | SOLVAY PHARMACEUTICALS GMBH (DE) | 2007-07-26 | — | — | WO | claimed |
| US-20040266025-A1 | Screening and treatment methods for prevention of preterm delivery | CYTYC CORPORATION | 2004-12-30 | — | — | US | claimed |
| US-6024974-A | TRANSDERMAL DRUG DELIVERY | NOVEN PHARMACEUTICALS, INC. (US) | 2000-02-15 | — | — | US | claimed |
| EP-0876131-A4 | — | — | 1998-12-02 | — | — | EP | claimed |
| EP-0876131-A1 | DRUG DELIVERY COMPOSITIONS FOR IMPROVED STABILITY OF STEROIDS | THERATECH, INC. (a Delaware Corporation) (US) | 1998-11-11 | — | — | EP | claimed |
| WO-1997003629-A1 | DRUG DELIVERY COMPOSITIONS FOR IMPROVED STABILITY OF STEROIDS | THERATECH, INC. (US) | 1997-02-06 | — | — | WO | claimed |
| US-4016270-A | Method for treating dysmenorrhea with a uterine therapeutic system | ALZA CORPORATION (US) | 1977-04-05 | — | — | US | claimed |
| US-4014988-A | Method for treating hypermenorrhea with uterine therapeutic system | ALZA CORPORATION (US) | 1977-03-29 | — | — | US | claimed |
| US-11992431-B2 | Inserter | BAYER OY (FI) | 2024-05-28 | — | — | US | disclosed |
| CN-107531746-B8 | Preparation method of 9 beta, 10 alpha-pregna-4,6-diene-3,20-dione | 台州市海盛制药有限公司 | 2023-11-10 | — | — | CN | disclosed |
| US-3993057-A | Intrauterine device that bioerodes in response to the environment of the uterus and method of using | ALZA CORPORATION (US) | 1976-11-23 | — | — | US | disclosed |
| US-3977404-A | OSMOTIC DEVICE HAVING MICROPOROUS RESERVOIR | ALZA CORPORATION (US) | 1976-08-31 | — | — | US | disclosed |
| US-3971367-A | Intrauterine device having means for changing from uterine-retentive shape to nonuterine-retentive shape | ALZA CORPORATION (US) | 1976-07-27 | — | — | US | disclosed |